Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21646 AL 21660

A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: clinical, neuroimaging, and neuropathological findings

Kim J, Bagyinszky E, Chang YH, Choe G, Choi BO, An SS, Kim S.

Neurosci Lett. 2012 Nov 21;530(2):109-14. doi: 10.1016/j.neulet.2012.09.040. Epub 2012 Oct 6.

Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome

Cárdenas AM, Ardiles AO, Barraza N, Baéz-Matus X, Caviedes P.

Arch Med Res. 2012 Nov;43(8):645-54. doi: 10.1016/j.arcmed.2012.10.012. Epub 2012 Nov 7.

Caregiver burden in Parkinson disease with dementia compared to Alzheimer disease in Korea

Shin H, Youn J, Kim JS, Lee JY, Cho JW.

J Geriatr Psychiatry Neurol. 2012 Dec;25(4):222-6. doi: 10.1177/0891988712464819. Epub 2012 Nov 21.

Different approaches, one target: understanding cellular mechanisms of Parkinson's and Alzheimer's diseases

Torrão AS, Café-Mendes CC, Real CC, Hernandes MS, Ferreira AF, Santos TO, Chaves-Kirsten GP, Mazucanti CH, Ferro ES, Scavone C, Britto LR.

Braz J Psychiatry. 2012 Oct;34 Suppl 2:S194-205. doi: 10.1016/j.rbp.2012.08.004.

Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand

Kulkantrakorn K, Tanyakitpisal P, Towanabut S, Dejthevaporn C, Rangseekajee P, Pongpakdee S, Laptikultham S, Rodprasert K, Setthawatcharawanich S, Thinkhamrop B.

Psychogeriatrics. 2013 Mar;13(1):1-8. doi: 10.1111/j.1479-8301.2012.00403.x. Epub 2012 Feb 17.

Frontotemporal dementia: implications for understanding Alzheimer disease

Goedert M, Ghetti B, Spillantini MG.

Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006254. doi: 10.1101/cshperspect.a006254.

Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia

Hardenacke K, Kuhn J, Lenartz D, Maarouf M, Mai JK, Bartsch C, Freund HJ, Sturm V.

World Neurosurg. 2013 Sep-Oct;80(3-4):S27.e35-43. doi: 10.1016/j.wneu.2012.12.005. Epub 2012 Dec 12.

Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease

Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD.

Pharmacol Biochem Behav. 2011 Sep;99(3):414-22. doi: 10.1016/j.pbb.2011.05.026. Epub 2011 May 27.

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease

Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group.

Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.

Presenile dementia: a case of Hashimoto's encephalopathy

Chong CS, Leung JL, Wong IH, Ng PW, Miao MY.

East Asian Arch Psychiatry. 2011 Mar;21(1):32-6.

Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein

Shimada H, Ataka S, Tomiyama T, Takechi H, Mori H, Miki T.

Dement Geriatr Cogn Disord. 2011;32(1):45-54. doi: 10.1159/000330017. Epub 2011 Aug 13.

Impaired ideomotor limb apraxia in cortical and subcortical dementia: a comparison of Alzheimer's and Huntington's disease

Holl AK, Ille R, Wilkinson L, Otti DV, Hödl E, Herranhof B, Reisinger KM, Müller N, Painold A, Holl EM, Letmaier M, Bonelli RM.

Neurodegener Dis. 2011;8(4):208-15. doi: 10.1159/000322230. Epub 2011 Jan 5.

The role of CREB signaling in Alzheimer's disease and other cognitive disorders

Saura CA, Valero J.

Rev Neurosci. 2011;22(2):153-69. doi: 10.1515/RNS.2011.018.

The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?

Arribas-Ayllon M.

Br Med Bull. 2011;100:7-21. doi: 10.1093/bmb/ldr023. Epub 2011 Jun 14.

Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development

Ehrnhoefer DE, Wong BK, Hayden MR.

Nat Rev Drug Discov. 2011 Oct 21;10(11):853-67. doi: 10.1038/nrd3556.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias